WO2011040221A1 - Ensemble aiguille de seringue et dispositif de seringue pour médicament - Google Patents

Ensemble aiguille de seringue et dispositif de seringue pour médicament Download PDF

Info

Publication number
WO2011040221A1
WO2011040221A1 PCT/JP2010/065746 JP2010065746W WO2011040221A1 WO 2011040221 A1 WO2011040221 A1 WO 2011040221A1 JP 2010065746 W JP2010065746 W JP 2010065746W WO 2011040221 A1 WO2011040221 A1 WO 2011040221A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
needle tube
tube
hub
skin
Prior art date
Application number
PCT/JP2010/065746
Other languages
English (en)
Japanese (ja)
Inventor
横田　崇之
陽一郎 岩瀬
資文 菱川
英司 柳下
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2011534177A priority Critical patent/JP5604438B2/ja
Priority to CN2010800255852A priority patent/CN102470216A/zh
Priority to US13/496,162 priority patent/US20120179113A1/en
Priority to ES10820340.7T priority patent/ES2532736T3/es
Priority to EP10820340.7A priority patent/EP2484397B1/fr
Publication of WO2011040221A1 publication Critical patent/WO2011040221A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3287—Accessories for bringing the needle into the body; Automatic needle insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205—Vaccinating by means of needles or other puncturing devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222—Materials for reducing friction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw

Definitions

  • the present invention relates to an injection needle assembly and a drug injection device in which a needle hub is formed on a needle tube by insert molding.
  • an injection needle assembly is composed of a needle tube having a needle tip that can puncture a living body at a distal end portion, and a needle hub that holds the needle tube with the needle tip of the needle tube protruding.
  • the medicine injection device is configured by connecting a syringe to the needle hub.
  • the needle tube is fixed to the needle hub using an adhesive while being inserted into the insertion hole of the needle hub (see, for example, Patent Document 1).
  • the needle hub is integrally formed with the needle tube by insert molding while the needle tube is held by the chuck member.
  • the needle hub when the needle hub is formed into a needle tube by insert molding, it is necessary to hold the needle tube at the time of molding. Therefore, when the length of the needle tube protruding from the needle hub is very short, it is difficult to support and fix the needle tube with the chuck member at the time of injection molding or assembly. Even when the needle tube can be supported at both ends in the axial direction, if the needle tube is thin, the needle tube may be deformed or bent by the molding pressure generated during molding. As described above, the conventional injection needle assembly has a problem that the needle tube and the needle hub cannot be integrally formed by insert molding because the needle tube cannot be reliably supported and fixed by the chuck member. It was.
  • an object of the present invention is to provide an injection needle assembly and a medicine injection device that can securely hold a needle tube with a chuck member and integrally form a needle tube and a needle hub by insert molding. There is.
  • an injection needle assembly of the present invention holds a needle tube having a needle tip that can puncture a living body and a needle tube in a state in which the needle tip of the needle tube protrudes. And a needle hub formed with a holding hole through which a chuck member for supporting and fixing the peripheral surface of the needle tube at the time of insert molding is inserted.
  • the drug injection device of the present invention includes a needle tube having a needle tip that can be punctured into a living body, a needle hub that holds the needle tube with the needle tip protruding, and a syringe connected to the needle hub. I have. Further, the needle hub is formed with a holding hole through which a chuck member for supporting and fixing the peripheral surface of the needle tube at the time of insert molding is inserted.
  • the needle tube is formed not only on both ends in the axial direction but also on the periphery by forming the holding hole through which the chuck member for supporting and fixing the peripheral surface of the needle tube is formed in the needle hub. It can also be held from the surface.
  • the needle hub can be integrally formed on the needle tube by insert molding.
  • the needle tube and the needle hub can be integrally formed by insert molding, the bonding process between the needle tube and the needle hub can be reduced, and the cost can be reduced. Further, since the peripheral surface of the needle tube can also be held by the chuck, it is possible to prevent the needle tube from being deformed or bent by molding pressure during insert molding.
  • Embodiments of an injection needle assembly and a drug injection device according to the present invention will be described below with reference to FIGS.
  • symbol is attached
  • the present invention is not limited to the following form. The description will be given in the following order. 1. 1. Configuration example of injection needle assembly and drug injection device 2. Assembly of needle assembly and drug injection device 2-1. Assembly of the needle assembly 2-2. 2. Assembly of drug injection device Method of using drug injection device
  • FIG. 1 is a side view showing a drug injection device of this example
  • FIG. 2 is an exploded view showing the drug injection device of this example.
  • the drug injection device 1 is used to puncture the needle tip from the surface of the skin and inject the drug into the upper layer of the skin.
  • This medicine injection device 1 is composed of an injection needle assembly 2 and a syringe 3 to which the injection needle assembly 2 is detachably connected.
  • the skin is composed of three parts: epidermis, dermis, and subcutaneous tissue.
  • the epidermis is a layer of about 50 to 200 ⁇ m from the skin surface, and the dermis is a layer of about 1.5 to 3.5 mm continuing from the epidermis.
  • Influenza vaccines are generally administered subcutaneously or intramuscularly, and are therefore administered in the lower layer of the skin or deeper.
  • the upper skin layer refers to the epidermis and dermis of the skin.
  • the injection needle assembly 2 includes a hollow needle tube 5 having a needle hole, a needle hub 6 to which the needle tube 5 is fixed, an elastic member 7 disposed in the needle hub 6, and a needle hub. 6 and a cap 8 that is detachably attached.
  • the needle hub 6 includes a first member 11 that is a holding portion that holds the needle tube 5 and a second member 12 that is a connector portion to which the syringe 3 is connected.
  • FIG. 3 is a cross-sectional view of the drug injection device 1.
  • FIG. 4 is an exploded cross-sectional view of the medicine injection device 1.
  • the needle tube 5 of the injection needle assembly 2 has a size of 22 to 33 gauge (outer diameter 0.2 to 0.7 mm) based on the ISO medical needle tube standard (ISO9626: 1991 / Amd.1: 2001 (E)). Things can be used.
  • those having a gauge of 26 to 33 gauge can be used, preferably those having a gauge of 30 to 33 gauge.
  • a needle tip 5A having a blade surface 5a is provided at one end of the needle tube 5.
  • the other axial end of the needle tube 5 opposite to the needle tip 5A is hereinafter referred to as a base end 5B.
  • the axial length of the needle tube 5 on the blade surface 5a (hereinafter referred to as “bevel length B”) may be 1.4 mm (adult) or less, which is the thinnest thickness of the upper skin layer described later.
  • the bevel length may be about 0.5 mm or more when a short bevel is formed on a 33 gauge needle tube. That is, the bevel length B is preferably set in the range of 0.5 to 1.4 mm.
  • the bevel length B is more preferable if the thinnest thickness of the upper skin portion is 0.9 mm (child) or less, that is, the bevel length B is in the range of 0.5 to 0.9 mm.
  • the short bevel refers to a blade surface that is generally used for injection needles and forms an angle of 18 to 25 ° with respect to the longitudinal direction of the needle.
  • a coating agent made of, for example, a silicone resin or a fluorine resin is applied to the surface of the needle tip 5A of the needle tube 5.
  • the material of the needle tube 5 examples include stainless steel, but are not limited thereto, and aluminum, aluminum alloy, titanium, titanium alloy, and other metals can be used.
  • the needle tube 5 can be applied not only with a straight needle but also with a tapered needle at least partially having a tapered structure.
  • the tapered needle the proximal end portion has a larger diameter than the needle distal end portion, and the intermediate portion may have a tapered structure.
  • the cross-sectional shape of the needle tube 5 may be not only a circle but also a polygon such as a triangle. The needle tube 5 is fixed to the needle hub 6.
  • the first member 11 and the second member 12 of the needle hub 6 are formed as separate members, but may be formed integrally.
  • Examples of the material of the first member 11 and the second member 12 include synthetic resins such as polycarbonate, polypropylene, and polyethylene.
  • the first member 11 includes a substantially cylindrical base portion 15, an adjustment portion 16, a stabilization portion 17, and a guide portion 18.
  • the base portion 15 has end faces 15a and 15b perpendicular to the axial direction.
  • the adjustment portion 16 is provided at the center of the end surface 15 a on the one end side in the axial direction of the base portion 15, and is composed of a columnar convex portion protruding in the axial direction of the base portion 15.
  • the axis of the adjustment unit 16 is coincident with the axis of the base unit 15.
  • the needle tube 5 is provided so as to penetrate through the axis of the base portion 15 and the adjustment portion 16. That is, the needle tube 5 is formed integrally with the first member 11 by insert molding. Note that after the needle tube 5 and the first member 11 are integrally formed by insert molding, an adhesive is injected into the gap between the needle tube 5 and the first member so that the needle tube 5 and the first member 11 are securely fixed. Good.
  • the adjusting portion 16 is formed with a holding hole 26 communicating with the needle tube 5 from the peripheral surface.
  • the holding hole 26 is a through hole orthogonal to the axis of the adjustment unit 16.
  • a chuck member that supports and fixes the peripheral surface of the needle tube 5 is inserted into the holding hole 26.
  • the proximal end 5B side of the needle tube 5 protrudes from an end face 15b which is the other end of the base portion 15 in the axial direction.
  • the base portion 15 is inserted into the second member 12 from the end surface 15b side, and the proximal end 5B side of the needle tube 5 is inserted into an insertion hole 45 described later of the elastic member 7.
  • the end surface 15b of the base part 15 is contact
  • connection piece 24 is provided on the outer peripheral surface of the base portion 15.
  • the connection piece 24 is formed as a ring-shaped flange that protrudes outward in the radial direction of the base portion 15, and has flat surfaces 24 a and 24 b that face the axial direction of the base portion 15.
  • the second member 12 is connected to the flat surface 24 b of the connection piece 24.
  • the distal end portion of the connection piece 24 is a guide portion 18. The guide portion 18 will be described in detail later.
  • the base portion 15 is also provided with a holding hole 26 through which the chuck member is inserted, similarly to the adjustment portion 16.
  • a holding hole 26 through which the chuck member is inserted, similarly to the adjustment portion 16.
  • You may provide one or three or more holding holes.
  • the first member 11 is provided at substantially the center in the axial direction of the needle tube 5 in order to hold the needle tube 5 in a balanced manner.
  • the number of holding holes is one and the projection length differs from the first member 11 on both sides in the axial direction of the needle tube, the end portion of the first member 11 with the shorter projection length of the needle tube and the needle tube It is preferable that it is arrange
  • the end surface of the adjusting portion 16 is a needle projecting surface 16a from which the needle tip 5A side of the needle tube 5 projects.
  • the needle projecting surface 16 a is formed as a plane orthogonal to the axial direction of the needle tube 5.
  • This needle protrusion surface 16a defines the depth at which the needle tube 5 is punctured by contacting the surface of the skin when the needle tube 5 is punctured into the upper layer portion of the skin. That is, the depth at which the needle tube 5 is punctured into the upper skin layer is determined by the length of the needle tube 5 protruding from the needle protruding surface 16a (hereinafter referred to as “projection length L”).
  • the thickness of the upper skin portion corresponds to the depth from the skin surface to the dermis layer, and is generally in the range of 0.5 to 3.0 mm. Therefore, the protruding length L of the needle tube 5 can be set in the range of 0.5 to 3.0 mm.
  • the vaccine is generally administered to the upper arm, but when administration to the upper layer of the skin is considered, it is considered that the shoulder peripheral part where the skin is thick, particularly the deltoid part is suitable. Therefore, the thickness of the upper layer of the deltoid muscle was measured for 19 children and 31 adults. This measurement was performed by imaging the upper layer of the skin with high ultrasonic reflectivity using an ultrasonic measurement device (NP60R-UBM, high-resolution echo for small animals, Nepagene). In addition, since the measured value was logarithmic normal distribution, the range of MEAN ⁇ 2SD was obtained by geometric mean.
  • the thickness of the upper skin layer of the deltoid muscle of the child was 0.9 to 1.6 mm.
  • the thickness of the upper skin layer of the deltoid muscle of adults was 1.4 to 2.6 mm at the distal part, 1.4 to 2.5 mm at the central part, and 1.5 to 2.5 mm at the proximal part. It was. From the above, it was confirmed that the thickness of the upper skin layer in the deltoid muscle was 0.9 mm or more in the case of children and 1.4 mm or more in the case of adults. Therefore, in the injection in the upper layer part of the deltoid muscle, the protruding length L of the needle tube 5 is preferably set in the range of 0.9 to 1.4 mm.
  • the blade surface 5a of the needle tip 5A can be reliably positioned on the upper skin layer.
  • the needle hole (chemical solution discharge port) that opens in the blade surface 5a can be located in the upper skin layer portion at any position in the blade surface 5a. Even if the drug solution outlet is located in the upper skin layer, if the needle tip 5A is deeply stabbed into the upper skin layer, the drug solution flows subcutaneously between the side surface of the end of the needle tip 5A and the cut skin. Therefore, it is important that the blade surface 5a is surely in the upper skin portion.
  • the needle projecting surface 16a is formed so that the distance S from the peripheral edge to the peripheral surface of the needle tube 5 is 1.4 mm or less, preferably in the range of 0.3 to 1.4 mm.
  • the distance S from the peripheral edge of the needle protruding surface 16a to the peripheral surface of the needle tube 5 is set in consideration of the pressure applied to the blisters formed by administering the drug to the upper skin layer. That is, the needle projecting surface 16a is set to a size that is sufficiently smaller than the blisters formed on the upper layer portion of the skin and does not prevent the formation of blisters. As a result, it is possible to prevent the needle protruding surface 16a from pressing the skin around the needle tube 5 and leaking the administered medicine.
  • the stabilizing portion 17 is formed in a cylindrical shape protruding from the flat surface 24 a of the connecting piece 24 provided on the base portion 15.
  • the needle tube 5 and the adjustment unit 16 are disposed in the cylindrical hole of the stabilization unit 17. That is, the stabilizing portion 17 is formed in a cylindrical shape that covers the periphery of the adjusting portion 16 through which the needle tube 5 passes, and is provided away from the needle tip 5A of the needle tube 5 in the radial direction.
  • the stabilizing portion 17 is provided with a notch 27 at a position corresponding to the holding hole 26 provided in the adjusting portion 16.
  • the notch 27 prevents the stable portion 17 and the chuck member from interfering during insert molding, and ensures the operation of the chuck member.
  • the cap 8 is detachably fitted to the stabilizing portion 17 (see FIG. 1).
  • the cap 8 covers the needle tip 5 ⁇ / b> A of the needle tube 5.
  • needle tip 5A can be prevented from touching a user's fingertip.
  • the used medicine injection device 1 or the needle assembly 2 can be always kept in a safe state, and the user can safely dispose of the used medicine injection device 1 or the needle assembly 2. It can be carried out.
  • the end surface 17a of the stabilizing portion 17 is located closer to the proximal end 5B of the needle tube 5 than the needle protruding surface 16a of the adjusting portion 16.
  • the needle projecting surface 16a first contacts the surface of the skin, and then contacts the end surface 17a of the stabilizing portion 17.
  • the drug injection device 1 is stabilized by the end surface 17a of the stabilizing portion 17 coming into contact with the skin, and the needle tube 5 can be maintained in a posture substantially perpendicular to the skin.
  • the needle tube 5 is skinned. It is possible to keep the posture substantially perpendicular to the angle.
  • the axial distance between the end surface 17a of the stable portion 17 and the needle protruding surface 16a is preferably set to 1.3 mm or less.
  • the inner diameter d of the stable portion 17 is set to a value equal to or larger than the diameter of the blister formed on the skin.
  • the distance T from the inner wall surface of the stabilizing portion 17 to the peripheral edge of the needle protruding surface 16a is set to be in the range of 4 mm to 15 mm. Thereby, it can prevent that blister formation is inhibited by pressure being applied to a blister from the inner wall surface of stable part 17.
  • the shortest distance T from the inner wall surface of the stabilizing portion 17 to the outer peripheral surface of the adjusting portion 16 is not particularly limited as long as it is 4 mm or more.
  • the distance T is preferably set to 15 mm as a maximum in consideration of the thinness of the child's arm.
  • the adjusting unit 16 does not enter the skin. Therefore, considering the distance T (4 mm or more) from the inner wall surface of the stable portion 17 to the periphery of the needle protruding surface 16a and the diameter (about 0.3 mm) of the needle protruding surface 16a, the inner diameter d of the stable portion 17 is 9 mm or more. Can be set.
  • the shape of the stable part 17 is not limited to a cylindrical shape, and may be formed in a rectangular tube shape such as a quadrangular column or a hexagonal column having a cylindrical hole at the center.
  • the guide portion 18 is a tip side portion located on the outer side in the radial direction of the first member 11 with respect to the stabilizing portion 17 of the connection piece 24.
  • the guide portion 18 has a contact surface 18a that comes into contact with the skin.
  • the contact surface 18 a is a part of the flat surface 24 a of the connection piece 24, and is a flat surface that is substantially parallel to the end surface 17 a of the stabilizing portion 17.
  • the distance Y from the contact surface 18a of the guide portion 18 to the end surface 17a of the stable portion 17 punctures the needle tube 5 and the stable portion 17 by pressing the skin with an appropriate pressing force. Its length is set so that it can.
  • An appropriate pressing force of the needle tube 5 and the stabilizing portion 17 is, for example, 3 to 20N.
  • the guide portion 18 guides the user with the pressing force applied to the skin by the needle tube 5 and the stabilizing portion 17, and the needle tip 5 ⁇ / b> A (the blade surface 5 a) of the needle tube 5 can be reliably positioned at the upper skin portion. In addition to being able to give a sense of security to the user.
  • the guide portion height Y is appropriately determined based on the inner diameter d of the stable portion 17 and the length X from the distal end surface of the guide portion 18 to the outer peripheral surface of the stable portion 17 (hereinafter referred to as “guide portion length”).
  • guide portion length the guide portion height Y is set in the range of 2.3 to 6.6 mm.
  • the second member 12 is formed in a substantially cylindrical shape.
  • One end portion of the second member 12 in the axial direction is an insertion portion 31 into which the base portion 15 of the first member 11 is inserted, and the other end portion is an insertion portion into which a later-described discharge portion 52 of the syringe 3 is inserted.
  • the cylindrical hole 31 a of the insertion portion 31 is set to a size corresponding to the base portion 15 of the first member 11.
  • the insertion part 31 is provided with a fixing piece 34 connected to the connection piece 24 of the first member 11.
  • the fixing piece 34 is formed as a ring-shaped flange that protrudes radially outward continuously from the distal end of the insertion portion 31.
  • a flat surface 24b of the connection piece 24 provided on the first member 11 is brought into contact with and fixed to the fixed piece 34.
  • Examples of the fixing method of the fixing piece 34 and the connection piece 24 include an adhesive, ultrasonic welding, laser welding, and a fixing screw.
  • the cylinder hole 32a of the insertion portion 32 is set to a size corresponding to the discharge portion 52 of the syringe 3, and the diameter continuously decreases toward the insertion portion 31 side.
  • a thread groove 35 for screwing the discharge part 52 of the syringe 3 is formed on the inner surface of the fitting part 32.
  • the engaging portion 37 is formed as a step portion protruding radially inward from the inner surface of the second member 12, and has engaging surfaces 37 a and 37 b that are substantially orthogonal to the axial direction of the second member 12. .
  • a flange portion 42 described later of the elastic member 7 is engaged with the engagement surface 37a of the engagement portion 37, and a stopper projection 43 of the elastic member 7 is engaged with the engagement surface 37b.
  • the elastic member 7 is disposed in the second member 12 of the needle hub 6 and is interposed between the first member 11 and the syringe 3.
  • the elastic member 7 includes a main body 41, a flange 42 provided at one end of the main body 41 in the axial direction, and a stopper protrusion 43 provided at the other end of the main body 41.
  • the main body 41 is formed in a substantially cylindrical shape and has end faces 41a and 41b perpendicular to the axial direction.
  • the end surface 15a of the base portion 15 of the first member 11 is in contact with the end surface 41a of the main body portion 41, and the tip of the discharge portion 52 provided in the syringe 3 is in liquid-tight contact with the end surface 41b. That is, the end surface 41b is an abutting surface with which the tip of the discharge portion 52 abuts in a liquid-tight manner.
  • the main body portion 41 is provided with an insertion hole 45 through which the proximal end 5B side of the needle tube 5 protruding from the end surface 15b of the base portion 15 is inserted.
  • the insertion hole 45 extends in the axial direction of the main body 41 and is opened in the end faces 41a and 41b.
  • the inner surface of the main body 41 is formed by an end surface side separation portion 46, a contact surface side separation portion 47, and a close contact portion 48.
  • the end surface side separation portion 46 forms an opening of the insertion hole 45 in the end surface 41a.
  • the end surface side separation portion 46 is separated from the outer peripheral surface of the needle tube 5 and is formed in a taper shape such that the diameter of the insertion hole 45 continuously increases toward the end surface 41a. Thereby, the base end 5B side of the needle tube 5 protruding from the end surface 15b of the base portion 15 can be easily inserted into the insertion hole 45.
  • the shape of the end face side separation portion 46 in the insertion hole 45 is not limited to a tapered shape as long as the needle tube 5 can be easily inserted into the insertion hole 45.
  • the contact surface side separation portion 47 forms an opening of the insertion hole 45 in the end surface 41b.
  • the contact surface side separation portion 47 is separated from the outer peripheral surface of the needle tube 5, and is formed in a taper shape such that the diameter of the insertion hole 45 continuously increases toward the end surface 41b.
  • the contact surface side separation portion 47 in the insertion hole 45 is not limited to the one formed in a taper shape, and is, for example, a concave portion that is larger than the diameter of the contact portion 48 and is separated from the outer peripheral surface of the needle tube 5.
  • the shape of the contact surface side separation portion 47 in the insertion hole 45 may be any shape that can prevent the end surface 41b side of the main body portion 41 from elastically deforming and covering the proximal end 5B of the needle tube 5 and closing the needle hole. .
  • the contact portion 48 is formed between the end surface side separation portion 46 and the contact surface side separation portion 47.
  • the close contact portion 48 is in liquid tight contact with the outer peripheral surface of the needle tube 5. Thereby, the medicine in the syringe 3 can be prevented from penetrating from between the needle tube 5 and the elastic member 7 to the first member 11 side of the needle hub 6.
  • the flange portion 42 is formed in a ring shape that protrudes radially outward from the outer peripheral surface of the main body portion 41.
  • the outer diameter of the flange portion 42 is substantially equal to the outer diameter of the base portion 15 of the first member 11. Therefore, one flat surface of the flange portion 42 abuts on the engagement surface 37 a of the engagement portion 37 provided on the second member 12, and the other flat surface abuts on the end surface 15 b of the base portion 15 of the first member 11. .
  • the elastic member 7 is attached to the needle hub 6 by sandwiching the flange portion 42 between the engaging portion 37 of the second member 12 and the base portion 15 of the first member 11.
  • the stopper protrusion 43 is formed in a ring shape that protrudes radially outward from the outer peripheral surface of the main body 41, similarly to the flange 42.
  • the stopper protrusion 43 engages with the engagement surface 37 b of the engagement portion 37 provided on the second member 12.
  • the elastic member 7 is locked to move in the axial direction by the flange portion 42 and the stopper projection 43 engaging the engaging portion 37 of the second member 11.
  • Examples of the material of the elastic member 7 include various rubber materials such as natural rubber and silicone rubber, various thermoplastic elastomers such as polyurethane and styrene, or mixtures thereof.
  • the syringe 3 includes a syringe body 51 and a discharge unit 52 that is continuous with the syringe body 51.
  • the syringe body 51 is a circular cylinder.
  • the discharge part 52 protrudes from one end of the syringe body 51 in the axial direction, and is formed of a circular cylinder having an outer diameter smaller than that of the syringe body 51.
  • the discharge part 52 is formed in a taper shape whose diameter continuously decreases toward the tip.
  • An end surface 52a that is the tip of the discharge portion 52 is a plane that is orthogonal to the axial direction, and is in liquid-tight contact with the end surface 41b of the elastic member 7. Further, on the outer peripheral surface of the discharge portion 52, a screw portion 53 for screwing with the second member 12 of the needle hub 6 is provided.
  • a gasket (not shown) is accommodated in the syringe body 51.
  • a space in the syringe body 51 is partitioned by a gasket, and one space communicating with the discharge portion 52 forms a liquid chamber 56 together with the space in the discharge portion 52.
  • a plunger (not shown) is arranged in the other space in the syringe body 51. The plunger is connected to the gasket and protrudes from the opening at the other end of the syringe body 51. By operating this plunger, the gasket is moved in the axial direction within the syringe main body 51, and the medicine is sucked into the liquid chamber 56 and the medicine filled in the liquid chamber 56 is discharged.
  • synthetic resins such as polycarbonate, polypropylene, and polyethylene may be used, and metals such as stainless steel and aluminum may be used.
  • FIG. 5 is a side view of a state in which the first member 11 and the needle tube 5 are integrally formed.
  • the needle tip 5A and the base end 5B that are both ends in the axial direction of the needle tube 5 and the side surface of the needle tube 5 are supported and fixed by a chuck member.
  • insert molding is performed to form the first member 11 around the needle tube 5.
  • the length (protrusion length L) by which the needle tip 5A of the needle tube 5 projects from the first member 11 is set in the range of 0.9 to 1.4 mm, and the proximal end 5B of the needle tube 5 is the first.
  • the length is set shorter than the length protruding from the member 11.
  • two holding holes 26 and notches 27 into which the chuck member has been inserted are formed on the side surface of the first member 11. Thereby, the attaching operation of the needle tube 5 is completed, and the first member 11 holds the needle tube 5.
  • the needle tube 5 and the first member 11 can be integrally formed by insert molding, the bonding process using an adhesive can be omitted, and the assembling process can be simplified.
  • an adhesive may be injected from the holding hole 26 formed in the base portion 15.
  • a coating agent made of silicone resin, fluorine resin, or the like is applied to the needle tip 5A of the needle tube 5.
  • an extra coating agent enters the gap between the needle tube 5 and the first member 11 due to capillary action.
  • excess coating agent can be discharged to the outside from the gap between the needle tube 5 and the first member 11 from the holding hole 26 provided in the adjusting portion 16.
  • the second member 12 with the elastic member 7 engaged in advance is connected to the first member 11 holding the needle tube 5. That is, the base portion 15 of the first member 11 and the proximal end 5B side of the needle tube 5 are inserted into the insertion portion 31 of the second member 12, and the connection piece 24 of the first member 11 is fixed to the fixing piece 34 of the second member 12. Make contact. At this time, the proximal end 5B side of the needle tube 5 is inserted into the insertion hole 45 of the elastic member 7 disposed in the second member 12, and is in close contact with the contact portion 48 (see FIG. 3). Thereafter, the fixing piece 34 of the second member 12 is fixed to the connection piece 24 of the first member 11 by a fixing method such as adhesive, ultrasonic welding, laser welding, fixing screw, or the like. Thereby, the assembly of the injection needle assembly 2 is completed.
  • a fixing method such as adhesive, ultrasonic welding, laser welding, fixing screw, or the like.
  • the method for assembling the injection needle assembly 2 is not limited to the above-described method.
  • the first method is performed.
  • the member 11 and the second member 12 may be connected.
  • the end surface 17a of the stabilizing portion 17 is opposed to the skin.
  • the needle tip 5A of the needle tube 5 is opposed to the skin to be punctured.
  • the drug injection device 1 is moved substantially perpendicularly to the skin, and the needle tip 5A is punctured into the skin and the end surface 17a of the stabilizing portion 17 is pressed against the skin.
  • the needle protruding surface 16a can come into contact with the skin to deform the skin flatly, and the needle tip 5A side of the needle tube 5 can be punctured into the skin by the protruding length L.
  • the end surface 17a of the stabilizing portion 17 is pressed until the contact surface 18a of the guide portion 18 contacts the skin.
  • the length of the guide portion height y (see FIG. 3) is set so that the needle tube 5 and the stabilizing portion 17 can puncture the skin with an appropriate pressing force. Therefore, the force that presses the skin by the stabilizing portion 17 becomes a predetermined value.
  • the user can recognize an appropriate pressing force of the stabilizing portion 17, and the needle tip 5A and the blade surface 5a of the needle tube 5 can be surely positioned on the upper skin portion.
  • the guide part 18 becomes a mark for recognizing an appropriate pressing force of the stable part 17, so that the user can use the medicine injection device 1 with peace of mind.
  • the stabilizing portion 17 contacts the skin, the posture of the medicine injection device 1 is stabilized, and the needle tube 5 can be punctured straight to the skin. Moreover, the blurring which arises in the needle tube 5 after puncture can be prevented, and the administration of the medicine can be performed stably.
  • the skin may not stick into the skin even if the needle tip is brought into contact with the skin.
  • the skin inside the stable portion 17 is pulled and tension is applied to the skin. Therefore, it is difficult for the skin to escape from the needle tip 5 ⁇ / b> A of the needle tube 5. Therefore, by providing the stabilizing portion 17, it is possible to obtain an effect that the needle tip 5A is more easily pierced into the skin.
  • the plunger (not shown) is pushed to move the gasket (not shown) to the discharge part 52 side.
  • the medicine filled in the liquid chamber 56 of the syringe 3 is pushed out from the discharge part 52, passes through the needle hole of the needle tube 5, and is injected into the upper skin part from the needle tip 5 ⁇ / b> A.
  • the remaining amount of the medicine can be reduced.
  • the present invention is not limited to the embodiment described above and shown in the drawings, and various modifications can be made without departing from the scope of the invention described in the claims.
  • the injection needle assembly may be configured without providing the elastic member.
  • the second member and the elastic member may be integrally formed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un ensemble aiguille de seringue configuré de telle manière qu'un tube d'aiguille et un pavillon d'aiguille soient moulés ensemble de façon intégrée par moulage avec insert tandis que le tube d'aiguille est soutenu et immobilisé de manière fiable par un organe de mandrin. Un ensemble aiguille de seringue selon l'invention est muni d'un tube (5) d'aiguille doté d'une pointe (5A) d'aiguille susceptible d'être insérée dans un corps vivant, et d'un pavillon (6) d'aiguille qui maintient le tube (5) d'aiguille en faisant dépasser la pointe (5A) d'aiguille du tube (5) d'aiguille et dans lequel est formé un trou (26) de maintien à travers lequel est inséré un organe de mandrin, ledit organe de mandrin soutenant et immobilisant la surface périphérique du tube (5) d'aiguille au cours d'une opération de moulage avec insert.
PCT/JP2010/065746 2009-09-30 2010-09-13 Ensemble aiguille de seringue et dispositif de seringue pour médicament WO2011040221A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2011534177A JP5604438B2 (ja) 2009-09-30 2010-09-13 注射針組立体および薬剤注射装置
CN2010800255852A CN102470216A (zh) 2009-09-30 2010-09-13 注射针组装体和药剂注射装置
US13/496,162 US20120179113A1 (en) 2009-09-30 2010-09-13 Syringe needle assembly and medication syringe device
ES10820340.7T ES2532736T3 (es) 2009-09-30 2010-09-13 Conjunto de aguja de jeringa y dispositivo de jeringa de medicación
EP10820340.7A EP2484397B1 (fr) 2009-09-30 2010-09-13 Ensemble aiguille de seringue et dispositif de seringue pour médicament

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009228548 2009-09-30
JP2009-228548 2009-09-30

Publications (1)

Publication Number Publication Date
WO2011040221A1 true WO2011040221A1 (fr) 2011-04-07

Family

ID=43826047

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/065746 WO2011040221A1 (fr) 2009-09-30 2010-09-13 Ensemble aiguille de seringue et dispositif de seringue pour médicament

Country Status (6)

Country Link
US (1) US20120179113A1 (fr)
EP (1) EP2484397B1 (fr)
JP (1) JP5604438B2 (fr)
CN (1) CN102470216A (fr)
ES (1) ES2532736T3 (fr)
WO (1) WO2011040221A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012043544A1 (fr) * 2010-09-29 2012-04-05 テルモ株式会社 Seringue pourvue d'une aiguille
WO2012147409A1 (fr) * 2011-04-28 2012-11-01 テルモ株式会社 Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
WO2012147408A1 (fr) * 2011-04-28 2012-11-01 テルモ株式会社 Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
WO2012153563A1 (fr) * 2011-05-10 2012-11-15 テルモ株式会社 Ensemble aiguille d'injection et dispositif d'injection de médicament
JP2015066105A (ja) * 2013-09-27 2015-04-13 テルモ株式会社 注射針組立体
JP2017099451A (ja) * 2015-11-30 2017-06-08 株式会社タスク マルチニードルタイプの注射針組立体

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5960609B2 (ja) 2010-02-01 2016-08-02 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 低用量で事前充填式の薬剤送達デバイス
CA2888788C (fr) 2012-10-19 2021-06-01 Amgen Inc. Auto-injecteur ameliore
GB2519973B (en) * 2013-11-01 2017-06-14 Consort Medical Plc Medicament delivery device sub-assembly
DE102014114941A1 (de) * 2014-10-15 2016-04-21 Endress + Hauser Gmbh + Co. Kg Hybrid-Flansch
JP6636503B2 (ja) * 2015-03-27 2020-01-29 テルモ株式会社 注射針組立体および薬剤注射装置
GB201520043D0 (en) 2015-11-13 2015-12-30 Smiths Medical Int Ltd Needle assemblies and methods of manufacture

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08597A (ja) * 1994-06-20 1996-01-09 Misawa Ika Kogyo Kk 採血用穿針装置
JP2006116163A (ja) 2004-10-25 2006-05-11 Arkray Inc ランセットの製造方法およびランセット
WO2007111519A1 (fr) * 2006-03-29 2007-10-04 'htl-Strefa' Spolka Akcyjna Lancette
JP2008307423A (ja) * 2001-07-11 2008-12-25 Arkray Inc ランセットおよび穿刺装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913869D0 (en) * 1999-06-16 1999-08-11 Owen Mumford Ltd Improvements relating to lancets
GB0030489D0 (en) * 2000-12-14 2001-01-24 Owen Mumford Ltd Improvements relating to blood sampling device
US6595960B2 (en) * 2001-04-12 2003-07-22 Becton, Dickinson And Company Flexible needle assembly
GB0214373D0 (en) * 2002-06-21 2002-07-31 Owen Mumford Ltd Improvements relating to finger pricking lancets
US6589261B1 (en) * 2002-08-19 2003-07-08 Vitalcare Group, Inc. Lancet needle anchor and method
US7842008B2 (en) * 2005-11-21 2010-11-30 Becton, Dickinson And Company Intradermal delivery device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08597A (ja) * 1994-06-20 1996-01-09 Misawa Ika Kogyo Kk 採血用穿針装置
JP2008307423A (ja) * 2001-07-11 2008-12-25 Arkray Inc ランセットおよび穿刺装置
JP2006116163A (ja) 2004-10-25 2006-05-11 Arkray Inc ランセットの製造方法およびランセット
WO2007111519A1 (fr) * 2006-03-29 2007-10-04 'htl-Strefa' Spolka Akcyjna Lancette

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2484397A4 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012043544A1 (fr) * 2010-09-29 2012-04-05 テルモ株式会社 Seringue pourvue d'une aiguille
US10384379B2 (en) 2010-09-29 2019-08-20 Terumo Kabushiki Kaisha Syringe with needle
EP2703028A4 (fr) * 2011-04-28 2014-10-08 Terumo Corp Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
EP2703027A4 (fr) * 2011-04-28 2014-10-08 Terumo Corp Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
CN103501846A (zh) * 2011-04-28 2014-01-08 泰尔茂株式会社 注射针组装体及药剂注射装置
CN103501845A (zh) * 2011-04-28 2014-01-08 泰尔茂株式会社 注射针组装体及药剂注射装置
EP2703027A1 (fr) * 2011-04-28 2014-03-05 Terumo Kabushiki Kaisha Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
EP2703028A1 (fr) * 2011-04-28 2014-03-05 Terumo Kabushiki Kaisha Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
WO2012147408A1 (fr) * 2011-04-28 2012-11-01 テルモ株式会社 Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
US10967134B2 (en) 2011-04-28 2021-04-06 Terumo Kabushiki Kaisha Injection needle assembly and medicine injection device
EP2703028B1 (fr) * 2011-04-28 2021-03-24 Terumo Kabushiki Kaisha Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
JP5894582B2 (ja) * 2011-04-28 2016-03-30 テルモ株式会社 注射針組立体及び薬剤注射装置
JP5955838B2 (ja) * 2011-04-28 2016-07-20 テルモ株式会社 注射針組立体及び薬剤注射装置
US10398851B2 (en) 2011-04-28 2019-09-03 Terumo Kabushiki Kaisha Injection needle assembly and medicine injection device
WO2012147409A1 (fr) * 2011-04-28 2012-11-01 テルモ株式会社 Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
WO2012153563A1 (fr) * 2011-05-10 2012-11-15 テルモ株式会社 Ensemble aiguille d'injection et dispositif d'injection de médicament
JP2015066105A (ja) * 2013-09-27 2015-04-13 テルモ株式会社 注射針組立体
JP2017099451A (ja) * 2015-11-30 2017-06-08 株式会社タスク マルチニードルタイプの注射針組立体

Also Published As

Publication number Publication date
JPWO2011040221A1 (ja) 2013-02-28
US20120179113A1 (en) 2012-07-12
ES2532736T3 (es) 2015-03-31
EP2484397A1 (fr) 2012-08-08
EP2484397A4 (fr) 2013-05-29
EP2484397B1 (fr) 2015-01-21
CN102470216A (zh) 2012-05-23
JP5604438B2 (ja) 2014-10-08

Similar Documents

Publication Publication Date Title
JP5604438B2 (ja) 注射針組立体および薬剤注射装置
JP6284595B2 (ja) 注射針組立体及び薬剤注射装置
JP5726741B2 (ja) 注射針組立体および薬剤注射装置
JP5719522B2 (ja) 薬剤投与器具及び薬剤注射装置
JP6636503B2 (ja) 注射針組立体および薬剤注射装置
JP5618989B2 (ja) 注射針組立体および薬剤注射装置
JP5667571B2 (ja) 注射針組立体及び薬剤注射装置
JP5894582B2 (ja) 注射針組立体及び薬剤注射装置
JP5756793B2 (ja) 注射針組立体及び薬剤注射装置
WO2016158144A1 (fr) Dispositif d'injection de médicament
JP5955838B2 (ja) 注射針組立体及び薬剤注射装置
WO2012153563A1 (fr) Ensemble aiguille d'injection et dispositif d'injection de médicament
WO2011040222A1 (fr) Ensemble aiguille hypodermique et dispositif d'injection de médicament
WO2012160852A1 (fr) Ensemble aiguille d'injection et dispositif d'injection de médicament
WO2012157313A1 (fr) Unité aiguille d'injection
WO2012157318A1 (fr) Ensemble d'aiguille d'injection et dispositif d'injection de médicament
WO2012132761A1 (fr) Unité d'aiguille d'injection, étui de stockage, ensemble d'aiguille d'injection et dispositif d'injection de médicament
WO2012157312A1 (fr) Unité aiguille d'injection
WO2011040188A1 (fr) Aide à l'injection et dispositif de seringue de médicament

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080025585.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10820340

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2011534177

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 13496162

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2010820340

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE